Tatiana J. Carneiro's academic career is based in the Biochemistry field. She concluded the BSc degree in 2015 and the MSc degree in Biomolecular Methods in 2017, both at University of Aveiro, with scientific work developed within the scope of metabolomics. In 2018, she worked as a research fellow on the BioIMPACT project, which aimed to evaluate the metabolic impact of new-synthetized complex Palladium(II)-spermine as a potential antineoplastic agent with lower cytotoxicity than the conventional drug cisplatin. From 2019 to 2024, she enrolled in the PhD in Biochemistry at the University of Aveiro, focusing on identifying biomarkers of the in vitro and in vivo metabolic impact of metal-based drugs, as potential new low-toxic therapeutic agents against triple-negative breast cancer. The work developed until the present has led to fifteen publications in peer-reviewed journals, with Tatiana J. Carneiro as the first author in nine papers. She is currently working as a postdoc fellow at the Body Barrier Immunometabolism laboratory, at CNC - University of Coimbra, and she is enrolled in the project Kinder-GUT (financed by “La Caixa” - CaixaResearch Health 2022).